Atara Biotherapeutics Tech Stack

Atara Biotherapeutics uses 8 technology products and services including cdnjs, WordPress, OneTrust, and more. Explore Atara Biotherapeutics's tech stack below.

  • cdnjs
    Content Delivery Network
  • WordPress
    Content Management System
  • OneTrust
    Cookie Compliance
  • Google Maps
    Maps
  • HTTP/3
    Miscellaneous
  • Microsoft Azure
    Platform As A Service
  • Yoast SEO Premium
    Search Engines
  • Tailwind CSS
    UI Frameworks

Media & News

Atara Biotherapeutics's Email Address Formats

Atara Biotherapeutics uses at least 4 format(s):
Atara Biotherapeutics Email FormatsExamplePercentage
lfirst@atarabio.comDJohn@atarabio.com
48%
first@atarabio.comJohn@atarabio.com
26%
first.last@atarabio.comJohn.Doe@atarabio.com
25%
fmiddlelast@atarabio.comJMichaelDoe@atarabio.com
1%

Frequently Asked Questions

Where is Atara Biotherapeutics's headquarters located?

Minus sign iconPlus sign icon
Atara Biotherapeutics's main headquarters is located at 2380 Conejo Spectrum St Suite 200 Thousand Oaks, CA 91320 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Atara Biotherapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Atara Biotherapeutics's main corporate office by phone at +1-650-278-8930. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Atara Biotherapeutics's stock symbol?

Minus sign iconPlus sign icon
Atara Biotherapeutics is a publicly traded company; the company's stock symbol is ATRA.

What is Atara Biotherapeutics's official website and social media links?

Minus sign iconPlus sign icon
Atara Biotherapeutics's official website is atarabio.com and has social profiles on LinkedIn.

How much revenue does Atara Biotherapeutics generate?

Minus sign iconPlus sign icon
As of March 2024, Atara Biotherapeutics's annual revenue reached $75M.

What is Atara Biotherapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Atara Biotherapeutics's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Atara Biotherapeutics have currently?

Minus sign iconPlus sign icon
As of March 2024, Atara Biotherapeutics has approximately 344 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: S. T.CEO: I. C.Chief Financial Officer: E. H.. Explore Atara Biotherapeutics's employee directory with LeadIQ.

What industry does Atara Biotherapeutics belong to?

Minus sign iconPlus sign icon
Atara Biotherapeutics operates in the Biotechnology Research industry.

What technology does Atara Biotherapeutics use?

Minus sign iconPlus sign icon
Atara Biotherapeutics's tech stack includes cdnjsWordPressOneTrustGoogle MapsHTTP/3Microsoft AzureYoast SEO PremiumTailwind CSS.

What is Atara Biotherapeutics's email format?

Minus sign iconPlus sign icon
Atara Biotherapeutics's email format typically follows the pattern of lfirst@atarabio.com. Find more Atara Biotherapeutics email formats with LeadIQ.

How much funding has Atara Biotherapeutics raised to date?

Minus sign iconPlus sign icon
As of March 2024, Atara Biotherapeutics has raised $15M in funding. The last funding round occurred on Jan 08, 2024.

When was Atara Biotherapeutics founded?

Minus sign iconPlus sign icon
Atara Biotherapeutics was founded in 2012.
Atara Biotherapeutics

Atara Biotherapeutics

Biotechnology ResearchCalifornia, United States201-500 Employees

Atara Biotherapeutics Inc., is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative off-the-shelf therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases.  

With our lead program receiving marketing authorization in Europe, Atara is the most advanced allogeneic T-cell immunotherapy company and intends to rapidly deliver off-the-shelf treatments to patients with high unmet medical need. Our platform leverages the unique biology of EBV T cells and has the capability to treat a wide range of EBV-associated diseases, or other serious diseases through incorporation of engineered CARs (chimeric antigen receptors) or TCRs (T-cell receptors). Atara is applying this one platform, which does not require TCR or HLA gene editing, to create a robust pipeline including: tab-cel for Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) and other EBV-driven diseases; ATA188, a T-cell immunotherapy targeting EBV antigens as a potential treatment for multiple sclerosis; and multiple next-generation chimeric antigen receptor T-cell (CAR-T) immunotherapies for both solid tumors and hematologic malignancies.  

Section iconCompany Overview

Headquarters
2380 Conejo Spectrum St Suite 200 Thousand Oaks, CA 91320 US
Phone number
+1-650-278-8930
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
ATRA
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2012
Employees
201-500

Section iconFunding & Financials

  • $15M

    Atara Biotherapeutics has raised a total of $15M of funding over 8 rounds. Their latest funding round was raised on Jan 08, 2024.

  • $50M$100M

    Atara Biotherapeutics's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $15M

    Atara Biotherapeutics has raised a total of $15M of funding over 8 rounds. Their latest funding round was raised on Jan 08, 2024.

  • $50M$100M

    Atara Biotherapeutics's revenue is in the range of $50M$100M

© LeadIQ, Inc. All rights reserved.